CARTESIAN THERAPEUTICS INC (RNAC) Stock Analyst Ratings
USA - NASDAQ:RNAC - US8162123025 - Common Stock
7.87 USD
+0.32 (+4.24%)
7.66 USD
-0.21 (-2.67%)
ChartMill assigns a Buy % Consensus number of 83% to RNAC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 37.16. This target is 372.14% above the current price.
RNAC was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RNAC.
In the previous month the buy percentage consensus was at a similar level.
RNAC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-09 | Wedbush | Initiate | Outperform |
| 2025-05-08 | Needham | Maintains | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-13 | Needham | Reiterate | Buy -> Buy |
| 2025-01-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-27 | Needham | Reiterate | Buy -> Buy |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2024-12-19 | BTIG | Initiate | Buy |
| 2024-12-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | Needham | Reiterate | Buy -> Buy |
| 2024-11-25 | Needham | Reiterate | Buy -> Buy |
| 2024-11-08 | Needham | Reiterate | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-16 | Needham | Reiterate | Buy -> Buy |
| 2024-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-09 | Needham | Maintains | Buy -> Buy |
| 2024-08-06 | TD Cowen | Initiate | Buy |
| 2024-07-08 | Needham | Reiterate | Buy -> Buy |
| 2024-07-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-02 | Oppenheimer | Downgrade | Outperform -> Peer Perform |
| 2024-07-01 | Needham | Reiterate | Buy -> Buy |
| 2024-06-24 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-06-04 | Oppenheimer | Initiate | Outperform |
CARTESIAN THERAPEUTICS INC / RNAC FAQ
What is the price target for RNAC stock?
15 analysts have analysed RNAC and the average price target is 37.16 USD. This implies a price increase of 372.14% is expected in the next year compared to the current price of 7.87.
What is the consensus rating for RNAC stock?
The consensus rating for CARTESIAN THERAPEUTICS INC (RNAC) is 82.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.